{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Lincoln",
      "state": "NE",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "65422",
      "recalling_firm": "Novartis Consumer Health",
      "address_1": "10401 Hwy 6",
      "address_2": "N/A",
      "postal_code": "68517-9626",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide, Puerto Rico, Brazil and Panama",
      "recall_number": "D-844-2013",
      "product_description": "Excedrin Migraine (Acetaminophen 250 mg, Aspirin (NSAID) 250 mg and Caffeine 65 mg), a) 2-count tablets packaged in pouches, Distributed by Novartis Consumer Health, Inc., Parsippany, NJ, NDC 0067 203 702     Foreign packaging: b) Excedrin Migrana (Acetaminophen 250 mg, Aspirin 250 mg and 65 mg Caffeine) 2-ct pouches.  The foreign packaging do not have NDC numbers",
      "product_quantity": "10,624,000 pouches",
      "reason_for_recall": "Defective container: products are packaged in pouches which may not have been fully sealed",
      "recall_initiation_date": "20130606",
      "center_classification_date": "20130806",
      "termination_date": "20141104",
      "report_date": "20130814",
      "code_info": "Lot  # a) 10116809, Exp 5/13    Foreign: Lot #s b) 10115644 Exp 5/13; 10118226 Exp 5/13; 10118227 Exp 6/13; 10118228  Exp 6/13; 10121956 Exp 8/13 and 10121957 Exp 8/13"
    }
  ]
}